The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels

European Journal of Haematology

Volumn 85, Issue 2, 2010, Pages 108-113

  Bachmann, Hagen S ^a   Novotny, Jürgen ^a   Sixt, Stephan ^a,b   Liebisch, Peter ^c   Frey, Ulrich H ^a   Dührsen, Ulrich ^a   Siffert, Winfried ^a   Nückel, Holger ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

multiple myeloma; polymorphism; proteasome; PSMA6

Indexed keywords

MESSENGER RNA; PROTEASOME; PSMA6 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ALLELES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; SURVIVAL RATE;

EID: 77954699156     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01455.x     Document Type: Article

References (29)

1. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 1999 189 : 1815 1822.
2. Maki CG, Huibregtse JM, Howley PM. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 1996 56 : 2649 2654.
3. Salghetti SE, Kim SY, Tansey WP. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999 18 : 717 726.
4. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000 12 : 85 98.
5. Naujokat C, Hoffmann S. Role and function of the 26S proteasome in proliferation and apoptosis. Lab Invest 2002 82 : 965 980.
6. Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, Tachikawa T, Shin S, Ichihara A. Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci U S A 1990 87 : 7071 7075.
7. Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, Okada F, Sato S, Shimbara N, Ichihara A. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res 1991 51 : 6677 6685.
8. Bhui-Kaur A, Therwath A, Henry L, Chiesa J, Kurkure A, Scherrer K, Bureau JP. Increased prosomal proteins in breast cancer cells and in neighboring normal cells in Parsi and non-Parsi populations. J Cancer Res Clin Oncol 1998 124 : 117 126.
9. Chauhan D, Hideshima T, Anderson KC. Targeting proteasomes as therapy in multiple myeloma. Adv Exp Med Biol 2008 615 : 251 260.
10. Richardson PG, Sonneveld P, Schuster MW, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 2005 352 : 2487 2498.
11. San Miguel JF, Schlag R, Khuageva NK, et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med 2008 359 : 906 917.
12. Sixt SU, Dahlmann B. Extracellular, circulating proteasomes and ubiquitin - Incidence and relevance. Biochim Biophys Acta 2008 1782 : 817 823.
13. Lavabre-Bertrand T, Henry L, Carillo S, Guiraud I, Ouali A, Dutaud D, Aubry L, Rossi JF, Bureau JP. Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer 2001 92 : 2493 2500.
14. Stoebner PE, Lavabre-Bertrand T, Henry L, Guiraud I, Carillo S, Dandurand M, Joujoux JM, Bureau JP, Meunier L. High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br J Dermatol 2005 152 : 948 953.
15. Wada M, Kosaka M, Saito S, Sano T, Tanaka K, Ichihara A. Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance. J Lab Clin Med 1993 121 : 215 223.
16. Dutaud D, Aubry L, Henry L, Levieux D, Hendil KB, Kuehn L, Bureau JP, Ouali A. Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma. J Immunol Methods 2002 260 : 183 193.
17. Jakob C, Egerer K, Liebisch P, et al. Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 2007 109 : 2100 2105.
18. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996 65 : 801 847. (Pubitemid 26255262)
19. Bey F, Silva PI, Coux O, Viegas-Pequignot E, Recillas TF, Nothwang HG, Dutrillaux B, Scherrer K. The prosomal RNA-binding protein p27K is a member of the alpha-type human prosomal gene family. Mol Gen Genet 1993 237 : 193 205.
20. Ozaki K, Sato H, Iida A, et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet 2006 38 : 921 925.
21. Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Schiattarella C, Siciliano S, Lemme P, Paolisso G. The -8UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients. Atherosclerosis 2008 201 : 117 123.
22. Bennett DA, Xu P, Clarke R, Zondervan K, Parish S, Palmer A, Cardon L, Peto R, Lathrop M, Collins R. The exon 1-8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction in 6946 cases and 2720 controls from a United Kingdom population. Eur J Hum Genet 2008 16 : 480 486.
23. Sjakste T, Poudziunas I, Ninio E, et al. SNPs of PSMA6 gene - investigation of possible association with myocardial infarction and type 2 diabetes mellitus. Genetika 2007 43 : 553 559.
24. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 2009 27 : 88 94.
25. Takashima N, Shioji K, Kokubo Y, Okayama A, Goto Y, Nonogi H, Iwai N. Validation of the association between the gene encoding proteasome subunit alpha type 6 and myocardial infarction in a Japanese population. Circ J 2007 71 : 495 498.
26. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975 36 : 842 854.
27. Mearini G, Schlossarek S, Willis MS, Carrier L. Ubiquitin-proteasome system in cardiac dysfunction. Biochim Biophys Acta 2008 1782 : 749 763.
28. Li ZW, Chen H, Campbell RA, Bonavida B, Berenson JR. NF-kappaB in the pathogenesis and treatment of multiple myeloma. Curr Opin Hematol 2008 15 : 391 399.
29. Baz A, Henry L, Caravano R, Scherrer K, Bureau JP. Changes in the subunit distribution of prosomes (MCP-proteasomes) during the differentiation of human leukemic cells. Int J Cancer 1997 72 : 467 476.